Cargando…

Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments

OBJECTIVE: Estimate the prevalence of psychotropic drugs use in the city of Rio de Janeiro, Brazil, and establish its relationship with the presence of mental disorders. METHODS: A probabilistic sample of non-institutionalized individuals, from the general population of Rio de Janeiro (n = 1208;turn...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintana, Maria Ines, Andreoli, Sergio B., Moreira, Fernanda G., Ribeiro, Wagner S., Feijo, Marcelo M., Bressan, Rodrigo A., Coutinho, Evandro S. F., Mari, Jair J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653914/
https://www.ncbi.nlm.nih.gov/pubmed/23690934
http://dx.doi.org/10.1371/journal.pone.0062270
_version_ 1782269474636824576
author Quintana, Maria Ines
Andreoli, Sergio B.
Moreira, Fernanda G.
Ribeiro, Wagner S.
Feijo, Marcelo M.
Bressan, Rodrigo A.
Coutinho, Evandro S. F.
Mari, Jair J.
author_facet Quintana, Maria Ines
Andreoli, Sergio B.
Moreira, Fernanda G.
Ribeiro, Wagner S.
Feijo, Marcelo M.
Bressan, Rodrigo A.
Coutinho, Evandro S. F.
Mari, Jair J.
author_sort Quintana, Maria Ines
collection PubMed
description OBJECTIVE: Estimate the prevalence of psychotropic drugs use in the city of Rio de Janeiro, Brazil, and establish its relationship with the presence of mental disorders. METHODS: A probabilistic sample of non-institutionalized individuals, from the general population of Rio de Janeiro (n = 1208;turn out:81%), 15 years or older, who were interviewed using the Composite International Diagnostic Interview 2.1 (depression, anxiety-phobia, OCD\PTSD, alcoholism sections), and asked about their psychotropic use during a 12 and one-month period before the interview. Data were collected between June/2007-February/2008.The prevalence was estimated with a confidence interval of 95%. The associations between psychotropics use and mental disorders were analyzed through a logistic regression model (Odds Ration – OR). RESULTS: The one-month prevalence of psychotropic drug use was 6.55%, 3.19% for men and 9.13% for women. Antidepressants were the most frequently used drug (2.78%), followed by anorectics (1.65%), tranquilizers (1.61%) and mood stabilizers (1.23%). General practitioners issued the highest number of prescriptions (46.3%), followed by psychiatrists (29.3%); 86.6% of the psychotropic drugs used were paid for by the patient himself. Individuals with increased likelihood of using psychotropic drugs were those that had received a psychiatric diagnosis during a one-month period before the study (OR:3.93), females (OR:1.82), separated/divorced (OR:2.23), of increased age (OR:1.03), with higher income (OR:2.96), and family history of mental disorder (OR:2.59); only 16% of the individuals with a current DSM IV diagnosis were using a psychotropic drug; 17% among individuals with a depression-related diagnosis and 8% with Phobic Anxiety Disorders-related diagnosis used psychotropics. CONCLUSION: Approximately 84% of individuals displaying some mental disorder did not use psychotropic drugs, which indicates an important gap between demand and access to treatment. A significant failure is evident in the health system for patients with mental disorders; this could be due to health workers' inability to recognize mental disorders among individuals.
format Online
Article
Text
id pubmed-3653914
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36539142013-05-20 Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments Quintana, Maria Ines Andreoli, Sergio B. Moreira, Fernanda G. Ribeiro, Wagner S. Feijo, Marcelo M. Bressan, Rodrigo A. Coutinho, Evandro S. F. Mari, Jair J. PLoS One Research Article OBJECTIVE: Estimate the prevalence of psychotropic drugs use in the city of Rio de Janeiro, Brazil, and establish its relationship with the presence of mental disorders. METHODS: A probabilistic sample of non-institutionalized individuals, from the general population of Rio de Janeiro (n = 1208;turn out:81%), 15 years or older, who were interviewed using the Composite International Diagnostic Interview 2.1 (depression, anxiety-phobia, OCD\PTSD, alcoholism sections), and asked about their psychotropic use during a 12 and one-month period before the interview. Data were collected between June/2007-February/2008.The prevalence was estimated with a confidence interval of 95%. The associations between psychotropics use and mental disorders were analyzed through a logistic regression model (Odds Ration – OR). RESULTS: The one-month prevalence of psychotropic drug use was 6.55%, 3.19% for men and 9.13% for women. Antidepressants were the most frequently used drug (2.78%), followed by anorectics (1.65%), tranquilizers (1.61%) and mood stabilizers (1.23%). General practitioners issued the highest number of prescriptions (46.3%), followed by psychiatrists (29.3%); 86.6% of the psychotropic drugs used were paid for by the patient himself. Individuals with increased likelihood of using psychotropic drugs were those that had received a psychiatric diagnosis during a one-month period before the study (OR:3.93), females (OR:1.82), separated/divorced (OR:2.23), of increased age (OR:1.03), with higher income (OR:2.96), and family history of mental disorder (OR:2.59); only 16% of the individuals with a current DSM IV diagnosis were using a psychotropic drug; 17% among individuals with a depression-related diagnosis and 8% with Phobic Anxiety Disorders-related diagnosis used psychotropics. CONCLUSION: Approximately 84% of individuals displaying some mental disorder did not use psychotropic drugs, which indicates an important gap between demand and access to treatment. A significant failure is evident in the health system for patients with mental disorders; this could be due to health workers' inability to recognize mental disorders among individuals. Public Library of Science 2013-05-14 /pmc/articles/PMC3653914/ /pubmed/23690934 http://dx.doi.org/10.1371/journal.pone.0062270 Text en © 2013 Quintana et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Quintana, Maria Ines
Andreoli, Sergio B.
Moreira, Fernanda G.
Ribeiro, Wagner S.
Feijo, Marcelo M.
Bressan, Rodrigo A.
Coutinho, Evandro S. F.
Mari, Jair J.
Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments
title Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments
title_full Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments
title_fullStr Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments
title_full_unstemmed Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments
title_short Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments
title_sort epidemiology of psychotropic drug use in rio de janeiro, brazil: gaps in mental illness treatments
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653914/
https://www.ncbi.nlm.nih.gov/pubmed/23690934
http://dx.doi.org/10.1371/journal.pone.0062270
work_keys_str_mv AT quintanamariaines epidemiologyofpsychotropicdruguseinriodejaneirobrazilgapsinmentalillnesstreatments
AT andreolisergiob epidemiologyofpsychotropicdruguseinriodejaneirobrazilgapsinmentalillnesstreatments
AT moreirafernandag epidemiologyofpsychotropicdruguseinriodejaneirobrazilgapsinmentalillnesstreatments
AT ribeirowagners epidemiologyofpsychotropicdruguseinriodejaneirobrazilgapsinmentalillnesstreatments
AT feijomarcelom epidemiologyofpsychotropicdruguseinriodejaneirobrazilgapsinmentalillnesstreatments
AT bressanrodrigoa epidemiologyofpsychotropicdruguseinriodejaneirobrazilgapsinmentalillnesstreatments
AT coutinhoevandrosf epidemiologyofpsychotropicdruguseinriodejaneirobrazilgapsinmentalillnesstreatments
AT marijairj epidemiologyofpsychotropicdruguseinriodejaneirobrazilgapsinmentalillnesstreatments